MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
European Journal of Cancer
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

655 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
655 works in the cohort · of 4,299,418page 12 of 14

Labels cover 1 of 655 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 655 of 655 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Expression of the sortilin 1 receptor (SORT1) in healthy and tumor tissues
Guylaine Roy, P. Kadekar, L.M. Douglas, Jean-Christophe Currie, Jesryn Dhillon, G. Cesarone +4 more
2022· article· en· European Journal of Cancer· Pharmacology, Toxicology and Pharmaceutics
distilled prediction:candidate · insufficient_payloadconsensus · none
3
citations
affno abstractunlabeled
The unclear zone in phase II clinical trials
S. M. Allegro, Gregory R. Pond, Sebastién J. Hotte
2010· review· en· European Journal of Cancer· Mathematics
distilled prediction:candidate · metaresearch+research_integrityconsensus · metaresearch
2
citations
affno abstractunlabeled
Getting under the skin
Jean‐Michel Lavoie, Karen A. Gelmon
2017· letter· en· European Journal of Cancer· Medicine
distilled prediction:candidate · research_integrity+insufficient_payloadconsensus · none
1
citations
affaboutno abstractunlabeled
Incidence, prevalence and treatment of patients with Epithelioid Haemangioendothelioma (EHE) in Canada: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) and Multi-pronged Canadian Research in Epithelioid Haemangioendothelioma (PRO_CARE EHE) study
Catherine Weadick, Aisha Alshibany, M MICHAEL, Caroline L. Holloway, Xiaolan Feng, Christopher Lemieux +11 more
2025· article· en· European Journal of Cancer· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
affno abstractunlabeled
Recommendations from the European Commission Initiative on Breast Cancer on multigene tests to guide the use of adjuvant chemotherapy in patients who have hormone receptor positive, HER-2 negative, lymph node negative or up to 3 lymph nodes positive invasive breast cancer
Paolo Giorgi Rossi, Annette Lebeau, C. Canelo-Aybar, Machado Rivera, Dolors Comas, Caroline Quinn +10 more
2020· article· en· European Journal of Cancer· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
1
citations
affno abstractunlabeled
Reply to Verlingue, Koscielny and Ferté
Saskia Litière, Elisabeth G.E. de Vries, Lesley Seymour, Daniel J. Sargent, Lalitha Shankar, Jan Bogaerts
2014· letter· en· European Journal of Cancer· Medicine
distilled prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About